Share price: 104.00p

Year End 2012 Prelim Statement

13th March 2013

Solid overall 2012 performance – Cello Health continued growth; Cello Consumer H2 recovery

Cello Group plc (AIM:CLL, “Cello” or “the Group”), the insight and strategic marketing group, today announces its final audited results for the year to 31 December 2012.

Prelim Statement 2012

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150